237 related articles for article (PubMed ID: 14648207)
21. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
[TBL] [Abstract][Full Text] [Related]
23. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
Gu J; Liang D; Wang Y; Lu C; Wu X
Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore.
Seow A; Zhao B; Lee EJ; Poh WT; Teh M; Eng P; Wang YT; Tan WC; Lee HP
Carcinogenesis; 2001 Apr; 22(4):673-7. PubMed ID: 11285205
[TBL] [Abstract][Full Text] [Related]
25. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
[TBL] [Abstract][Full Text] [Related]
26. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
[TBL] [Abstract][Full Text] [Related]
27. Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer.
Yuan JM; Chan KK; Coetzee GA; Castelao JE; Watson MA; Bell DA; Wang R; Yu MC
Carcinogenesis; 2008 Jul; 29(7):1386-93. PubMed ID: 18544563
[TBL] [Abstract][Full Text] [Related]
28. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese.
Katoh T; Inatomi H; Yang M; Kawamoto T; Matsumoto T; Bell DA
Pharmacogenetics; 1999 Jun; 9(3):401-4. PubMed ID: 10471074
[No Abstract] [Full Text] [Related]
29. Genetic polymorphism of sulfotransferase 1A1, cigarette smoking, hazardous chemical exposure and urothelial cancer risk in a Taiwanese population.
Wang YH; Juang GD; Hwang TI; Shen CH; Shao KY; Chiou HY
Int J Urol; 2008 Dec; 15(12):1029-34. PubMed ID: 19120511
[TBL] [Abstract][Full Text] [Related]
30. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
[TBL] [Abstract][Full Text] [Related]
31. Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.
Koda M; Iwasaki M; Yamano Y; Lu X; Katoh T
Environ Health Prev Med; 2017 Oct; 22(1):72. PubMed ID: 29165164
[TBL] [Abstract][Full Text] [Related]
32. Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma.
Rouprêt M; Cancel-Tassin G; Comperat E; Fromont G; Sibony M; Molinié V; Allory Y; Triau S; Champigneulle J; Gaffory C; Larré S; de la Taille A; Richard F; Hamdy FC; Cussenot O
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2500-3. PubMed ID: 18006944
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population.
Boccia S; Sayed-Tabatabaei FA; Persiani R; Gianfagna F; Rausei S; Arzani D; La Greca A; D'Ugo D; La Torre G; van Duijn CM; Ricciardi G
BMC Cancer; 2007 Nov; 7():206. PubMed ID: 17996038
[TBL] [Abstract][Full Text] [Related]
34. Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.
Avirmed S; Khuanbai Y; Sanjaajamts A; Selenge B; Dagvadorj BU; Ohashi M
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2479-2485. PubMed ID: 34452561
[TBL] [Abstract][Full Text] [Related]
35. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
36. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
[TBL] [Abstract][Full Text] [Related]
37. Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects.
Vaziri SA; Hughes NC; Sampson H; Darlington G; Jewett MA; Grant DM
Pharmacogenetics; 2001 Feb; 11(1):7-20. PubMed ID: 11207033
[TBL] [Abstract][Full Text] [Related]
38. Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.
Muscat JE; Pittman B; Kleinman W; Lazarus P; Stellman SD; Richie JP
Biochem Pharmacol; 2008 Oct; 76(7):929-37. PubMed ID: 18703023
[TBL] [Abstract][Full Text] [Related]
39. NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.
Matejcic M; Vogelsang M; Wang Y; Iqbal Parker M
BMC Cancer; 2015 Mar; 15():150. PubMed ID: 25886288
[TBL] [Abstract][Full Text] [Related]
40. Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas.
Tiemersma EW; Bunschoten A; Kok FJ; Glatt H; de Boer SY; Kampman E
Int J Cancer; 2004 Jan; 108(1):97-103. PubMed ID: 14618622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
